Breaking News
Sort by:
Date
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Peer-reviewed Research Finds Babylon's Digital-first Model of Primary Care is Associated With Lower Significantly NHS Hospital Care Costs
Researchers at Babylon, a leading digital-first value-based healthcare company, have found that members of Babylon’s […]
Babylon Hires Former White House Health Official Darshak Sanghavi as New Chief Medical Officer
Babylon today announced the hiring of Darshak Sanghavi, MD as the company’s new Global Chief […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more